M Holdings Securities Inc. Acquires Shares of 10,891 CVS Health Co. (NYSE:CVS)

M Holdings Securities Inc. bought a new stake in CVS Health Co. (NYSE:CVS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,891 shares of the pharmacy operator's stock, valued at approximately $489,000.

A number of other large investors have also recently bought and sold shares of the company. Ridgewood Investments LLC boosted its holdings in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC bought a new stake in CVS Health during the 4th quarter worth about $28,000. Hopwood Financial Services Inc. acquired a new position in shares of CVS Health during the 4th quarter worth about $29,000. Financial Perspectives Inc increased its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after acquiring an additional 466 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. raised its holdings in CVS Health by 112.1% during the fourth quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock worth $37,000 after acquiring an additional 437 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Stock Down 2.0 %

Shares of CVS stock traded down $1.37 during midday trading on Thursday, reaching $67.19. 16,054,208 shares of the stock were exchanged, compared to its average volume of 11,804,493. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a market cap of $84.71 billion, a PE ratio of 18.36, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. The company's 50 day moving average is $66.22 and its two-hundred day moving average is $58.76. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $71.45.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, equities research analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.96%. The ex-dividend date is Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 72.68%.

Insiders Place Their Bets

In related news, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.24% of the company's stock.

Analyst Ratings Changes

A number of research analysts have weighed in on CVS shares. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a research note on Tuesday. Piper Sandler upped their price target on shares of CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research report on Friday, March 21st. Argus set a $77.00 price target on shares of CVS Health in a research note on Tuesday, February 18th. Mizuho upped their target price on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Wolfe Research raised their target price on shares of CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Four equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $71.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.